PMYZX
Price
$44.84
Change
+$0.35 (+0.79%)
Updated
Jul 3 closing price
Net Assets
5.63B
VSMPX
Price
$281.45
Change
+$2.40 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

PMYZX vs VSMPX

Header iconPMYZX vs VSMPX Comparison
Open Charts PMYZX vs VSMPXBanner chart's image
Putnam Core Equity Fund R
Price$44.84
Change+$0.35 (+0.79%)
VolumeN/A
Net Assets5.63B
Vanguard Total Stock Mkt Idx Instl Pls
Price$281.45
Change+$2.40 (+0.86%)
VolumeN/A
Net Assets1.82T
PMYZX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMYZX vs. VSMPX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMYZX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. PMYZX (5.63B). VSMPX pays higher dividends than PMYZX: VSMPX (1.22) vs PMYZX (0.23). PMYZX was incepted earlier than VSMPX: PMYZX (15 years) vs VSMPX (10 years). PMYZX (1.23) is less costly to investors than VSMPX (0.02). PMYZX is a more actively managed with annual turnover of: 17.00 vs. VSMPX (2.00). PMYZX has a lower initial minimum investment than VSMPX: PMYZX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 13.90 vs. PMYZX (9.16). VSMPX return over 5 years is better than : 95.69 vs. PMYZX (88.56).
PMYZXVSMPXPMYZX / VSMPX
Total Expense Ratio1.230.026,150%
Annual Report Gross Expense Ratio1.230.026,150%
Fund Existence15 years10 years-
Gain YTD5.8806.42692%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.63B1.82T0%
Annual Yield % from dividends0.231.2219%
Returns for 1 year9.1613.9066%
Returns for 3 years57.3262.1792%
Returns for 5 years88.5695.6993%
Returns for 10 years159.32189.2184%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
WHD45.270.01
+0.02%
Cactus
STT109.49N/A
N/A
State Street Corp